Beyond our exploration of tumor and immune cell interactions that are impacted by K17, the development of a platform for image analysis of multiplexed immunohistochemical protocols may also be applicable for the analysis of immune composition for solid tumors of other anatomic sites. This evidence concerns the gene KRT17 and neoplasm.